Design Therapeutics, Inc. (DSGN) short interest & options flow
NASDAQDesign Therapeutics reports tomorrow with short positioning meaningfully lower than the highs flagged ten days ago, but still elevated enough to shape the reaction. Short interest has pulled back from the 19.3% of free float reported on October 23 to 11.8% now, a notable unwinding over the past two weeks. The month-on-month figure still shows a 23% increase in shares short…
- Market cap
- $639M
- Next earnings
- 10 Mar 2027
Key data as of 7 Nov 2026

DSGN Stock Report — available now on ORTEX
A new long-form analysis for DSGN this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumDSGN news and analysis
RSSNo long-form analysis yet for DSGN. Pulse alerts and the live data picture are available on ORTEX.
Open DSGN on ORTEX →Want the live picture for DSGN?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DSGN — free to start on ORTEX.
Sign up for free →Open DSGN on ORTEX